Modafinil compositions
US7566805B2 · kind B2 · utility
3Cited by
1References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2004 |
| Grant date | Jul 28, 2009 |
| Priority date | — |
| Expiry date | Dec 20, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C317/38
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Co-crystals and solvates of racemic, enantiomerically pure, and enantiomerically mixed modafinil are formed and several important physical properties are modulated. The solubility, dissolution, bioavailability, dose response, and stability of modafinil can be modulated to improve efficacy in pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.